Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines : World Health Organization consultations, October 2021—March 2022

Prudden, Holly J.

Achilles, Sharon L.

Schocken, Celina

Broutet, Nathalie

Canfell, Karen

Akaba, Hiroki

Basu, Partha

Bhatla, Neerja

Chirenje, Z. Mike

Delany-Moretlwe, Sinead

Denny, Lynette

Gamage, Deepa G.

Herrero, Rolando

Hutubessy, Raymond

Villa, Luisa Lina

Murillo, Raul

Schiller, John T.

Stanley, Margaret

Temmerman, Marleen

Zhao, Fanghui

Ogilvie, Gina

Kaslow, David C.

Dull, Peter

Gottlieb, Sami L.

Therapeutic HPV Vaccine PPC Expert Consultation Group

Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc/4.0/